Boots, Britain's Premier chemist chain, on Thursday reported only a 6.7 percent rise in annual pre tax profits to 878.1 million pounds Lrb 998.6 million dollars Rrb, after withdrawing its heart drug from the market and expensive restructuring costs.
Boots kick profit higher.